CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Integrative Oncology

ONCOLOGY. Vol. 24 No. 5
INTEGRATIVE ONCOLOGY 

Selenium

Complementary Therapies, Herbs, and other OTC Agents

By Guest Editor Barrie Cassileth, PhD1 | April 20, 2010
1 Laurance S. Rockefeller Chair and Chief, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

The micronutrient selenium(Drug information on selenium) plays a protective role against oxidative injury and is important for regulating thyroid function. Dietary sources rich in selenium include whole grains, meats, seafood, poultry, and nuts. It is also available in supplement form, and marketing campaigns claim that selenium boosts immune function and prevents cardiovascular and rheumatic diseases, and cancer.

Data from epidemiologic studies and clinical trials indicate that selenium reduces the incidence of some cancers and can alleviate adverse effects associated with chemotherapy and radiation therapy. However, selenium supplementation is not effective in preventing prostate cancer, and long-term use may increase the risk of some skin cancers. Moreover, because selenium can enhance antioxidant effects, it may alter the actions of some chemotherapeutic agents.

—Barrie Cassileth, PhD

ALSO KNOWN AS: Selenocysteine, selenomethionine, selenate, selenite

SUMMARY: Selenium, an essential trace mineral, is an important component of antioxidant systems such as glutathione peroxidase. It also plays an important role in thyroid function. Selenium is obtained by consuming whole grains, meats, seafood, poultry, and nuts. It is also marketed as a supplement with claims that it boosts immune function and prevents cardiovascular and rheumatic diseases, as well as cancer.

Despite several studies, the role of selenium in reducing the risk of cardiovascular disease remains uncertain.1 Selenium supplementation was found to reduce the viral load in individuals infected with HIV.2 Research also indicates that selenium may improve glucose metabolism; it was not useful in preventing type 2 diabetes, and may increase risk.3

The importance of selenium in cancer prevention has been documented in epidemiologic studies and clinical intervention trials. Data suggest it may prevent gastrointestinal4 and lung cancers.5 Selenium supplementation resulted in significant reduction of side effects including hair loss, abdominal pain, and loss of appetite in ovarian cancer patients undergoing chemotherapy.6 It also reduced head and neck lymphedema7 and diarrhea associated with radiation therapy.8

However, the large Selenium and Vitamin E(Drug information on vitamin e) Cancer Prevention Trial (SELECT), based on previous data indicating that selenium and vitamin E reduced the incidence of prostate cancer, failed to support the protective effects of selenium. The trial was suspended in January 2009, when initial data analysis showed no reduction in the risk of prostate cancer with selenium alone or with vitamin E.9

TAKE HOME POINTS
• Selenium is found in whole grains, meats, seafood, poultry, and nuts.
 
• Selenium supplementation was shown to alleviate adverse effects associated with cancer treatments, but evidence of its chemopreventive potential is mixed.
 
• Cancer patients should consult their physicians before taking supplemental selenium because it may interfere with chemotherapy.
 

For additional information, visit the Memorial Sloan-Kettering Cancer Center Integrative Medicine Service website, "About Herbs," at http://www.mskcc.org/AboutHerbs.

A cross-sectional analysis of men with prostate cancer indicated that selenium levels may influence the risk of aggressive prostate cancer.10 Long-term use of selenium may increase the risk of certain types of skin cancer.11

ADVERSE REACTIONS: Case Report: Oral consumption of a sodium selenite supplement for treatment of prostate cancer resulted in the death of a 75-year-old man.12

Chronic Selenosis: Doses greater than 1,000 μg/d may result in muscle weakness, fatigue, peripheral neuropathy, dermatitis, nail and hair changes/loss, garlic breath/body odor, irritability, growth retardation, and hepatic necrosis.

Toxicity: Acute toxicity via selenium poisoning has occurred with either accidental or suicidal ingestion of gun bluing solution or sheep drench. Consumption of gram quantities of selenium can cause severe gastrointestinal and neurologic disturbances, acute respiratory distress syndrome, myocardial infarction, and renal failure.13

HERB-DRUG INTERACTIONS: High doses of selenium may decrease vitamin C absorption.13

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES:
1. Mozaffarian D: Int J Environ Res Public Health 6:1894-1916, 2009.
2. Hurwitz BE et al: Arch Intern Med 167:148-154, 2007.
3. Stranges S et al: Ann Intern Med 147:217-223, 2007.
4. Bjelakovic G et al: Lancet 364:1219-1228, 2004. 5. Zhuo H et al: Cancer Epidemiol Biomarkers Prev 13:771-778, 2004.
6. Sieja K et al: Gynecol Oncol 93:320-327, 2004.
7. Bruns F et al: Med Princ Pract 13:185-190, 2004.
8. Muecke R et al: Int J Radiat Oncol Biol Phys Feb 2, 2010 (epub ahead of print).
9. Lippman SM et al: JAMA 301:39-51, 2009.
10. Chan JM et al: J Clin Oncol 27:3577-3583, 2009.
11. Duffield-Lillico AJ et al: J Natl Cancer Inst 95:1477-1481, 2003.
12. See KA et al: Med J Aust 185:388-389, 2006.
13. Pronsky ZM: Power's and Moore's Food-Medication Interactions, 11th ed. Pottstown, Pa; Food Medication Interactions; 2000.


 
RELATED CONTENT

Physical Activity Across the Cancer Continuum
ONCOLOGY,  June 18, 2013
Exercise After Cancer Diagnosis: Time to Get Moving
ONCOLOGY,  June 18, 2013
The Role of Physical Activity in Cancer Prevention, Treatment, Recovery, and Survivorship
ONCOLOGY,  June 18, 2013
The Key to Reducing Quackery Lies in Healing Patients and Treating Their Experience
ONCOLOGY,  August 20, 2012
Quackery, Placebos, and Other Thoughts: An Integrative Oncologist’s Perspective
ONCOLOGY,  August 20, 2012
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Integrative Oncology
Evidence on Integrative Oncology
Guidelines on Integrative Oncology
Patient Education on Integrative Oncology
Clinical Trials on Integrative Oncology
Practical Articles on Integrative Oncology
Research and Reviews on Integrative Oncology
All "Integrative Oncology" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy